Gracell Biotechnologies Inc. (GRCL) Tops Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts GRCL Hot Sheet
Join SI Premium – FREE
Gracell Biotechnologies Inc. (NASDAQ: GRCL) reported Q1 EPS of ($0.07), $0.01 better than the analyst estimate of ($0.08).
For earnings history and earnings-related data on Gracell Biotechnologies Inc. (GRCL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfspeed (WOLF) Misses Q4 EPS by 174c; Offers Guidance
- TJX stock drops as profit outlook falls short of analyst estimates
- FOMC minutes from July 28-29th meeting
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
